Substrate
Topic

biohacking

4 stories related to this topic, newest first.

John Hancock CEO Unveils Longevity Preparedness Index at Annual SymposiumFortune
finance7 days agoDeveloping

John Hancock CEO Unveils Longevity Preparedness Index at Annual Symposium

John Hancock CEO Brooks Tingle introduced a new Longevity Preparedness Index at the company's third annual symposium, highlighting strategies for extended lifespans. The index, developed with MIT AgeLab, assesses readiness across eight domains amid rising U.S. median age and agin…

Fortune
1 source
Doctors Report Rise in Injectable Peptide Use and Associated Health Riskschannelnewsasia.com
world11 days agoDeveloping

Doctors Report Rise in Injectable Peptide Use and Associated Health Risks

Physicians at longevity clinics have observed increased interest in injectable peptides for weight loss and anti-aging. They report cases of adverse effects including allergic reactions and hormone disturbances from unauthorized use. Discussions with seven doctors highlight conce…

Insider
theverge.com
2 sources
Rise in Testing of Unregulated Peptides in UK Amid Weight-Loss and Wellness DemandSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
health29 days ago

Rise in Testing of Unregulated Peptides in UK Amid Weight-Loss and Wellness Demand

Laboratories in the UK and internationally are processing thousands of samples of unregulated peptides sent by consumers for quality verification. These substances, often marketed for weight loss, biohacking, and anti-aging, include experimental compounds like retatrutide, which…

The Guardian
2 sources
Podcast Examines Rise of Grey-Market Injectable Peptides Among BiohackersSubstrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)
technology30 days ago

Podcast Examines Rise of Grey-Market Injectable Peptides Among Biohackers

A Guardian podcast explores the growing use of unregulated injectable peptides such as BPC-157, GHK-Cu, and TB-500 by biohackers and health optimizers. The episode features journalist Adrienne Matei and Dr. Anna Barnard, an associate professor at Imperial College London who resea…

The Guardian
1 source